var data={"title":"Camphor poisoning in children","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Camphor poisoning in children</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/contributors\" class=\"contributor contributor_credentials\">Shan Yin, MD, MPH</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/contributors\" class=\"contributor contributor_credentials\">Michele M Burns, MD, MPH</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/contributors\" class=\"contributor contributor_credentials\">James F Wiley, II, MD, MPH</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Sep 04, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H2214023\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><a href=\"topic.htm?path=camphor-drug-information\" class=\"drug drug_general\">Camphor</a> is an essential oil originally derived from the camphor tree, <em>Cinnamomum camphora</em>, but now primarily produced from turpentine [<a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/abstract/1\" class=\"abstract_t\">1</a>]. It is a terpenoid, which is a large family of naturally occurring hydrocarbons. Pediatric overdose of camphor can cause refractory seizures. Despite this potential for serious toxicity, camphor-containing products remain widely available. </p><p>This topic will discuss the clinical features, diagnosis and management of <a href=\"topic.htm?path=camphor-drug-information\" class=\"drug drug_general\">camphor</a> poisoning in children. The approach to pediatric poisoning caused by over-the-counter (OTC) cough medications is discussed separately. (See <a href=\"topic.htm?path=over-the-counter-cough-and-cold-preparations-approach-to-pediatric-poisoning#H2365756\" class=\"medical medical_review\">&quot;Over-the-counter cough and cold preparations: Approach to pediatric poisoning&quot;, section on 'Approach'</a>.)</p><p class=\"headingAnchor\" id=\"H2214222\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Approximately 11,000 pediatric <a href=\"topic.htm?path=camphor-drug-information\" class=\"drug drug_general\">camphor</a> exposures are reported to United States poison control centers annually [<a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/abstract/2\" class=\"abstract_t\">2</a>]. Exploratory ingestion of camphor-containing products by children younger than six years of age is most common, accounting for about 80 percent of exposures. Rarely, excessive topical exposure by a caregiver has been described [<a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/abstract/3,4\" class=\"abstract_t\">3,4</a>]. Although the majority of exposures result in minor or no toxicity, refractory seizures can occur. (See <a href=\"#H2213337\" class=\"local\">'Clinical features'</a> below.) </p><p class=\"headingAnchor\" id=\"H2213331\"><span class=\"h1\">PHARMACOLOGY AND TOXICITY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><a href=\"topic.htm?path=camphor-drug-information\" class=\"drug drug_general\">Camphor</a> is marketed for topical use for cough suppression, nasal decongestion, cold sore ointments, muscle liniments, and rubefacients (<a href=\"image.htm?imageKey=EM%2F94904\" class=\"graphic graphic_table graphicRef94904 \">table 1</a>) [<a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/abstract/1\" class=\"abstract_t\">1</a>]. Preparations for treatment of cough and cold symptoms in children typically advise application of a thick layer to the chest or throat three to four times daily [<a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/abstract/5\" class=\"abstract_t\">5</a>]. Camphorated liquid for use in vaporizers is also available. Despite significant potential for toxicity, camphor products remain widely available. (See <a href=\"#H2213337\" class=\"local\">'Clinical features'</a> below.)</p><p class=\"headingAnchor\" id=\"H2214049\"><span class=\"h2\">Formulations</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In the United States, the concentration of over-the-counter (OTC) <a href=\"topic.htm?path=camphor-drug-information\" class=\"drug drug_general\">camphor</a> products is limited to 11 percent (<a href=\"image.htm?imageKey=EM%2F94904\" class=\"graphic graphic_table graphicRef94904 \">table 1</a>). Products from some foreign countries are unregulated and may not be labeled including solid camphor for religious ceremonies and pest control and liquid camphor for dermal and inhalational use [<a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/abstract/3,4\" class=\"abstract_t\">3,4</a>].</p><p class=\"headingAnchor\" id=\"H2214055\"><span class=\"h2\">Mechanism of action</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Research in animal models suggests that the transient receptor potential vanilloid (TRPV)1 channel and the transient receptor potential ankyrin (TRPA)1 channel may be important in mediating cough and that <a href=\"topic.htm?path=camphor-drug-information\" class=\"drug drug_general\">camphor</a> may desensitize these channels [<a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/abstract/6\" class=\"abstract_t\">6</a>].</p><p>Limited evidence in children suggests that <a href=\"topic.htm?path=camphor-drug-information\" class=\"drug drug_general\">camphor</a>, in combination with menthol and eucalyptus oil (Vick&rsquo;s Vaporub) may improve some symptoms in children with viral upper respiratory tract infections. As an example, in a trial of 138 children with cough and cold symptoms for several days, Vick&rsquo;s vaporub significantly decreased parental report of cough severity and the child&rsquo;s ability to sleep on the first night of use when compared to unmedicated petrolatum or no treatment [<a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/abstract/7\" class=\"abstract_t\">7</a>]. Adverse effects, primarily mild irritation of the skin, nose or eyes, was reported in 46 percent of the children receiving the camphor product compared with 2 to 6 percent of patients receiving petrolatum or no treatment. This study received support from the manufacturer.</p><p>In overdose, neurotoxicity is manifested by agitation and seizures soon after exposure. The mechanism of this action is unclear. </p><p class=\"headingAnchor\" id=\"H2214061\"><span class=\"h2\">Pharmacokinetics</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><a href=\"topic.htm?path=camphor-drug-information\" class=\"drug drug_general\">Camphor</a> is lipophilic and well-absorbed through the skin and mucous membranes, especially in young infants. Gastrointestinal absorption is rapid with an onset of action of toxic effects within 5 to 20 minutes and a peak effect at 90 minutes [<a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/abstract/1,8\" class=\"abstract_t\">1,8</a>]. The volume of distribution is 2 to 4 <span class=\"nowrap\">L/Kg</span> and protein binding is 61 percent. The half-life in an adult volunteer ranged from approximately 90 to 170 minutes [<a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/abstract/9\" class=\"abstract_t\">9</a>].</p><p class=\"headingAnchor\" id=\"H2214067\"><span class=\"h2\">Toxic amount</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Expert consensus suggests emergent evaluation for any child exposed to doses &gt;30 <span class=\"nowrap\">mg/kg</span> [<a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/abstract/8\" class=\"abstract_t\">8</a>]. Seizures are unlikely to occur at doses less than 10 <span class=\"nowrap\">mg/kg</span> [<a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/abstract/1\" class=\"abstract_t\">1</a>]. </p><p>Based upon case reports, the ingested toxic dose of <a href=\"topic.htm?path=camphor-drug-information\" class=\"drug drug_general\">camphor</a> is considered to be approximately 500 mg or approximately 30 to 50 <span class=\"nowrap\">mg/kg</span> (eg, equivalent to 5 mL [one swallow] of 10 percent topical camphor and 10 mL [two swallows] of 5 percent topical camphor). </p><p>Death due to refractory seizures or respiratory failure has been reported at ingested doses of 780 mg to over 1 g (&gt;60 <span class=\"nowrap\">mg/kg)</span> [<a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/abstract/8,10-13\" class=\"abstract_t\">8,10-13</a>]. </p><p>Toxicity from topical absorption of <a href=\"topic.htm?path=camphor-drug-information\" class=\"drug drug_general\">camphor</a> is less common than from ingestion but has been described after application of unlabeled camphor oil in a four month old infant [<a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/abstract/4\" class=\"abstract_t\">4</a>] and copious application of a labeled topical ointment hourly for 10 hours in a three year old child [<a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/abstract/3\" class=\"abstract_t\">3</a>].</p><p class=\"headingAnchor\" id=\"H2213337\"><span class=\"h1\">CLINICAL FEATURES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Key findings of <a href=\"topic.htm?path=camphor-drug-information\" class=\"drug drug_general\">camphor</a> poisoning include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>History of oral ingestion or topical exposure to a camphor-containing product</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Strong medicinal smell on the breath or if a topical exposure, on the skin</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Oropharyngeal irritation, such as burning or stinging </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Nausea, vomiting, and abdominal pain</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Seizures which may be the first sign of exposure [<a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/abstract/10\" class=\"abstract_t\">10</a>]</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Other central nervous system effects, including agitation, confusion, myoclonus, hyperreflexia, lethargy, <span class=\"nowrap\">and/or</span> coma</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Rarely, patients have experienced delirium and altered mental status lasting up to seven days after ingestion [<a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/abstract/14\" class=\"abstract_t\">14</a>]</p><p/><p>Additional studies are determined by the degree of toxicity as follows:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patients with altered mental status or seizures warrant measurement of rapid blood glucose, serum sodium, and serum or blood calcium</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patients with prolonged altered mental status or focal neurologic findings warrant neuroimaging.</p><p/><p class=\"headingAnchor\" id=\"H2213343\"><span class=\"h1\">DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of <a href=\"topic.htm?path=camphor-drug-information\" class=\"drug drug_general\">camphor</a> poisoning is based upon the typical clinical findings. History of camphor exposure is particularly important because many caregivers may be unaware of the dangers of camphor and not mention its use when seeking medical care [<a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/abstract/3\" class=\"abstract_t\">3</a>]. Thus, the clinician should directly question parents regarding camphor exposure when clinical findings are suggestive (eg, seizures of unknown cause), especially in communities or cultures where camphor is frequently used as a cold remedy. </p><p>Laboratory studies for diagnostic purposes are not typically helpful. <a href=\"topic.htm?path=camphor-drug-information\" class=\"drug drug_general\">Camphor</a> can be detected in both blood and urine, but testing is generally reserved for forensic cases because these studies are not readily available at most health care facilities and results do not correlate with the clinical course [<a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/abstract/1\" class=\"abstract_t\">1</a>]. Other nonspecific laboratory findings include leukocytosis, proteinuria, and transient elevation in hepatic transaminases [<a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/abstract/15-18\" class=\"abstract_t\">15-18</a>].</p><p class=\"headingAnchor\" id=\"H2213349\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There are many causes of seizures that deserve consideration when evaluating the patient with suspected <a href=\"topic.htm?path=camphor-drug-information\" class=\"drug drug_general\">camphor</a> intoxication. </p><p>Toxicological causes of seizures are extensive and include, but are not limited to the following toxins: </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Sympathomimetics</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cyclic antidepressants </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Anticholinergic agents (eg, antihistamines) </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=isoniazid-pediatric-drug-information\" class=\"drug drug_pediatric\">Isoniazid</a> </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Methylxanthines (eg, <a href=\"topic.htm?path=theophylline-pediatric-drug-information\" class=\"drug drug_pediatric\">theophylline</a> or caffeine)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Organophosphates </p><p/><p>Toxidromes, physical findings characteristic for specific toxins, can be helpful for determining the cause of seizure for many of these agents, including sympathomimetics, anticholinergic agents, and organophosphates (<a href=\"image.htm?imageKey=EM%2F71268\" class=\"graphic graphic_table graphicRef71268 \">table 2</a>). In addition to anticholinergic findings, cyclic antidepressants will often cause a constellation of symptoms other than seizures, including central nervous system (CNS) depression, hypotension, and widened QRS on EKG. (See <a href=\"topic.htm?path=tricyclic-antidepressant-poisoning#H3\" class=\"medical medical_review\">&quot;Tricyclic antidepressant poisoning&quot;, section on 'Clinical features'</a>.) </p><p>Seizures caused by <a href=\"topic.htm?path=isoniazid-pediatric-drug-information\" class=\"drug drug_pediatric\">isoniazid</a> are typically refractory to standard seizure treatment and usually respond only to treatment with pyridoxine. A history of a family member being treated for tuberculosis or travel to an endemic region may be a helpful clue. (See <a href=\"topic.htm?path=isoniazid-inh-poisoning#H4\" class=\"medical medical_review\">&quot;Isoniazid (INH) poisoning&quot;, section on 'Clinical features of acute toxicity'</a>.) </p><p>Unlike <a href=\"topic.htm?path=camphor-drug-information\" class=\"drug drug_general\">camphor</a>, acute methylxanthine toxicity typically results in significant tachycardia and tachyarrhythmias, tachypnea, and hypokalemia. (See <a href=\"topic.htm?path=theophylline-poisoning#H8\" class=\"medical medical_review\">&quot;Theophylline poisoning&quot;, section on 'Clinical features of overdose'</a>.) </p><p>Some common medical causes of status epilepticus and differentiating features from <a href=\"topic.htm?path=camphor-drug-information\" class=\"drug drug_general\">camphor</a> poisoning include (see <a href=\"topic.htm?path=clinical-features-and-complications-of-status-epilepticus-in-children#H12\" class=\"medical medical_review\">&quot;Clinical features and complications of status epilepticus in children&quot;, section on 'Causes'</a>):</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hypoglycemia &ndash; Low rapid blood sugar (see <a href=\"topic.htm?path=causes-of-hypoglycemia-in-infants-and-children\" class=\"medical medical_review\">&quot;Causes of hypoglycemia in infants and children&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Electrolyte imbalance (eg, hyponatremia or hypocalcemia) &ndash; Low serum sodium or calcium (see <a href=\"topic.htm?path=hyponatremia-in-children#H952883049\" class=\"medical medical_review\">&quot;Hyponatremia in children&quot;, section on 'Etiology'</a> and <a href=\"topic.htm?path=etiology-of-hypocalcemia-in-infants-and-children\" class=\"medical medical_review\">&quot;Etiology of hypocalcemia in infants and children&quot;</a>) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Central nervous system infection (eg, meningitis or encephalitis) &ndash; Fever <span class=\"nowrap\">and/or</span> meningismus</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Intracranial mass lesion &ndash; Suggested by signs of increased intracranial pressure (eg, morning headache with vomiting, papilledema, <span class=\"nowrap\">and/or</span> focal neurologic deficits)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Traumatic brain injury, especially abusive head trauma &ndash; Abusive head trauma may present with intracranial injury (eg, subdural hematoma) without an appropriate mechanism by history, retinal hemorrhages, skin bruising, <span class=\"nowrap\">and/or</span> fractures (see <a href=\"topic.htm?path=child-abuse-evaluation-and-diagnosis-of-abusive-head-trauma-in-infants-and-children#H2\" class=\"medical medical_review\">&quot;Child abuse: Evaluation and diagnosis of abusive head trauma in infants and children&quot;, section on 'Clinical features'</a>) </p><p/><p class=\"headingAnchor\" id=\"H2213355\"><span class=\"h1\">MANAGEMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Recommendations for the care of children with <a href=\"topic.htm?path=camphor-drug-information\" class=\"drug drug_general\">camphor</a> exposure are derived from case reports and expert consensus [<a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/abstract/1,8\" class=\"abstract_t\">1,8</a>]. Treatment of camphor poisoning is primarily supportive with special attention to management of seizures.</p><p class=\"headingAnchor\" id=\"H2214073\"><span class=\"h2\">Decontamination</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Any camphor-containing medicine that is on the skin should be removed using soap and lukewarm water. Hot water should not be used to prevent local vasodilation and increased absorption. Core temperature should be monitored during skin decontamination to avoid hypothermia. </p><p>Because <a href=\"topic.htm?path=camphor-drug-information\" class=\"drug drug_general\">camphor</a> is rapidly absorbed from the stomach and has the potential for causing sudden altered mental status and seizures soon after ingestion and based upon case reports and expert consensus, we suggest that children who ingest camphor <strong>not </strong>receive activated charcoal [<a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/abstract/8\" class=\"abstract_t\">8</a>]. Furthermore, gastric emptying with syrup of ipecac is <strong>contraindicated</strong>.</p><p class=\"headingAnchor\" id=\"H2214079\"><span class=\"h2\">Asymptomatic</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Asymptomatic patients and those children with only mild oropharyngeal or gastrointestinal irritation should be observed for a minimum of four hours. These patients warrant a bag and mask at the bedside and continuous monitoring of heart rate, respiratory rate, and pulse oximetry. The greatest risk for seizures is within the first two hours after ingestion. Patients who remain asymptomatic at four to six hours after exposure can be discharged to home. </p><p class=\"headingAnchor\" id=\"H2214085\"><span class=\"h2\">Seizures</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Seizures caused by <a href=\"topic.htm?path=camphor-drug-information\" class=\"drug drug_general\">camphor</a> poisoning typically occur soon after ingestion and can be brief. Treatment is warranted for patients with active seizures on arrival to the emergency department or if seizures recur. Benzodiazepines (eg, <a href=\"topic.htm?path=lorazepam-pediatric-drug-information\" class=\"drug drug_pediatric\">lorazepam</a>) are the first line treatment with repeat doses as necessary as shown in the table (<a href=\"image.htm?imageKey=PEDS%2F55368\" class=\"graphic graphic_table graphicRef55368 \">table 3</a>). If seizures are not controlled by appropriate doses of benzodiazepines, a second anticonvulsant agent such as <a href=\"topic.htm?path=phenobarbital-pediatric-drug-information\" class=\"drug drug_pediatric\">phenobarbital</a> should be administered. Other second-line agents, such as <a href=\"topic.htm?path=phenytoin-pediatric-drug-information\" class=\"drug drug_pediatric\">phenytoin</a> or <a href=\"topic.htm?path=fosphenytoin-pediatric-drug-information\" class=\"drug drug_pediatric\">fosphenytoin</a>, are unlikely to be effective in toxin-induced seizures. </p><p>Although unusual following <a href=\"topic.htm?path=camphor-drug-information\" class=\"drug drug_general\">camphor</a> poisoning, patients with refractory status epilepticus should receive further pharmacologic therapy based upon the patient&rsquo;s hemodynamic status (eg, continuous infusions of <a href=\"topic.htm?path=midazolam-pediatric-drug-information\" class=\"drug drug_pediatric\">midazolam</a>, <a href=\"topic.htm?path=propofol-pediatric-drug-information\" class=\"drug drug_pediatric\">propofol</a>, or <a href=\"topic.htm?path=pentobarbital-pediatric-drug-information\" class=\"drug drug_pediatric\">pentobarbital</a>). (See <a href=\"topic.htm?path=management-of-convulsive-status-epilepticus-in-children#H18020055\" class=\"medical medical_review\">&quot;Management of convulsive status epilepticus in children&quot;, section on 'Refractory seizures'</a>.)</p><p>Children who develop seizures after <a href=\"topic.htm?path=camphor-drug-information\" class=\"drug drug_general\">camphor</a> exposure warrant hospitalization. Once initial seizures are controlled most children fully recover and do not require seizure prophylaxis. </p><p>Extracorporeal removal (eg, hemodialysis or charcoal hemoperfusion) has not been shown to improve clinical outcomes in serious poisoned patients [<a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/abstract/1,8\" class=\"abstract_t\">1,8</a>]. Hemodialysis is unlikely to remove a significant amount of <a href=\"topic.htm?path=camphor-drug-information\" class=\"drug drug_general\">camphor</a> given its high volume of distribution and degree of protein binding. </p><p class=\"headingAnchor\" id=\"H2214719\"><span class=\"h1\">ADDITIONAL RESOURCES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In many countries regional poison control centers are available at all times for consultation on patients who are critically ill, require admission, or have clinical pictures that are unclear. </p><p>The World Health Organization provides a listing of international poison centers at its <a href=\"http://www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html&amp;token=vYXClxsD0hnrf4M8kYcoD1kMICrGjKQRRaFc8pA0pw9qlhpVmsmYh2e3Gi7webw9H9uSzH3nipQ0rPpTLYBWhGP+/wpQqUegRzvggwgKA6s=&amp;TOPIC_ID=94659\" target=\"_blank\" class=\"external\">website</a>.</p><p>To contact a regional poison control center in the United States, call 1-800-222-1222. </p><p class=\"headingAnchor\" id=\"H3150763423\"><span class=\"h1\">SOCIETY GUIDELINE LINKS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See <a href=\"topic.htm?path=society-guideline-links-general-measures-for-acute-poisoning-treatment\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: General measures for acute poisoning treatment&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2214514\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=camphor-drug-information\" class=\"drug drug_general\">Camphor</a>, a terpenoid hydrocarbon, is marketed for topical use for cough and nasal decongestion, cold sores, and muscle or joint pain (<a href=\"image.htm?imageKey=EM%2F94904\" class=\"graphic graphic_table graphicRef94904 \">table 1</a>). Although most pediatric exposures result in no or minimal symptoms, refractory seizures can occur. (See <a href=\"#H2214222\" class=\"local\">'Epidemiology'</a> above and <a href=\"#H2214049\" class=\"local\">'Formulations'</a> above.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Expert consensus suggests emergent evaluation for any child exposed to doses &gt;30 <span class=\"nowrap\">mg/kg</span>. Seizures are unlikely to occur at doses less than 10 <span class=\"nowrap\">mg/kg</span>. (See <a href=\"#H2214067\" class=\"local\">'Toxic amount'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Important findings of <a href=\"topic.htm?path=camphor-drug-information\" class=\"drug drug_general\">camphor</a> poisoning consist of ingestion or dermal exposure to a camphor-containing product, oropharyngeal <span class=\"nowrap\">and/or</span> gastrointestinal irritation, and seizures. (See <a href=\"#H2213337\" class=\"local\">'Clinical features'</a> above.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The diagnosis of <a href=\"topic.htm?path=camphor-drug-information\" class=\"drug drug_general\">camphor</a> poisoning is based upon clinical findings. History of camphor exposure is particularly important because many caregivers may be unaware of the dangers of camphor and not mention its use when seeking medical care. (See <a href=\"#H2213343\" class=\"local\">'Diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The differential diagnosis of <a href=\"topic.htm?path=camphor-drug-information\" class=\"drug drug_general\">camphor</a> poisoning includes toxicologic and other medical causes of refractory seizures. (See <a href=\"#H2213349\" class=\"local\">'Differential diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Treatment of <a href=\"topic.htm?path=camphor-drug-information\" class=\"drug drug_general\">camphor</a> poisoning consists of the following actions:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Removal of any camphor-containing medication from the skin using soap and lukewarm water. (See <a href=\"#H2214073\" class=\"local\">'Decontamination'</a> above.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>We suggest that children who ingest <a href=\"topic.htm?path=camphor-drug-information\" class=\"drug drug_general\">camphor</a> <strong>not </strong>receive activated charcoal (<a href=\"grade.htm?i=6\" class=\"grade\">Grade 2C</a>). Furthermore, gastric emptying with syrup of ipecac is <strong>contraindicated</strong>. (See <a href=\"#H2214073\" class=\"local\">'Decontamination'</a> above.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Asymptomatic patients and those children with only mild oropharyngeal or gastrointestinal irritation should be observed for a minimum of four hours. The greatest risk for seizures is within the first two hours after ingestion. (See <a href=\"#H2214079\" class=\"local\">'Asymptomatic'</a> above.) </p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Benzodiazepines (eg, <a href=\"topic.htm?path=lorazepam-pediatric-drug-information\" class=\"drug drug_pediatric\">lorazepam</a>) are the first line treatment for seizures with repeat doses as necessary as shown in the table (<a href=\"image.htm?imageKey=PEDS%2F55368\" class=\"graphic graphic_table graphicRef55368 \">table 3</a>). If seizures are not controlled by appropriate doses of benzodiazepines, a second anticonvulsant agent such as <a href=\"topic.htm?path=phenobarbital-pediatric-drug-information\" class=\"drug drug_pediatric\">phenobarbital</a> should be administered. (See <a href=\"#H2214085\" class=\"local\">'Seizures'</a> above.) </p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Patients with refractory status epilepticus should receive further pharmacologic therapy based upon the patient&rsquo;s hemodynamic status (eg, continuous infusions of <a href=\"topic.htm?path=midazolam-pediatric-drug-information\" class=\"drug drug_pediatric\">midazolam</a>, <a href=\"topic.htm?path=propofol-pediatric-drug-information\" class=\"drug drug_pediatric\">propofol</a>, or <a href=\"topic.htm?path=pentobarbital-pediatric-drug-information\" class=\"drug drug_pediatric\">pentobarbital</a>). (See <a href=\"#H2214085\" class=\"local\">'Seizures'</a> above and <a href=\"topic.htm?path=management-of-convulsive-status-epilepticus-in-children#H18020055\" class=\"medical medical_review\">&quot;Management of convulsive status epilepticus in children&quot;, section on 'Refractory seizures'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Consultation with a regional poison control center is encouraged for all symptomatic overdoses. To contact a regional poison control center call 1-800-222-1222 in the United States or consult the World Health Organization listing of international poison control centers at their <a href=\"http://www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html&amp;token=vYXClxsD0hnrf4M8kYcoD1kMICrGjKQRRaFc8pA0pw9qlhpVmsmYh2e3Gi7webw9H9uSzH3nipQ0rPpTLYBWhGP+/wpQqUegRzvggwgKA6s=&amp;TOPIC_ID=94659\" target=\"_blank\" class=\"external\">website</a>.</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li class=\"breakAll\">Caraccio TR, McGuigan MA. Over-the-counter products. In: Medical Toxicology, 3rd ed, Dart RC (Ed), Lippincott, Williams &amp; Wilkins, Philadelphia, PA 2004. p.1051.</li><li><a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/abstract/2\" class=\"nounderline abstract_t\">Mowry JB, Spyker DA, Cantilena LR Jr, et al. 2012 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 30th Annual Report. Clin Toxicol (Phila) 2013; 51:949.</a></li><li><a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/abstract/3\" class=\"nounderline abstract_t\">Khine H, Weiss D, Graber N, et al. A cluster of children with seizures caused by camphor poisoning. Pediatrics 2009; 123:1269.</a></li><li><a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/abstract/4\" class=\"nounderline abstract_t\">Guilbert J, Flamant C, Hallalel F, et al. Anti-flatulence treatment and status epilepticus: a case of camphor intoxication. Emerg Med J 2007; 24:859.</a></li><li class=\"breakAll\">Vicks VapoRub Topical Ointment Children's Cough Medicine. Procter &amp; Gamble. http://www.vicks.com/products/vapo-family/vaporub-topical-ointment/ (Accessed on April 16, 2014).</li><li><a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/abstract/6\" class=\"nounderline abstract_t\">Geppetti P, Benemei S, Patacchini R. Camphor, an old cough remedy with a new mechanism. Am J Respir Crit Care Med 2012; 185:342; author reply 343.</a></li><li><a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/abstract/7\" class=\"nounderline abstract_t\">Paul IM, Beiler JS, King TS, et al. Vapor rub, petrolatum, and no treatment for children with nocturnal cough and cold symptoms. Pediatrics 2010; 126:1092.</a></li><li><a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/abstract/8\" class=\"nounderline abstract_t\">Manoguerra AS, Erdman AR, Wax PM, et al. Camphor Poisoning: an evidence-based practice guideline for out-of-hospital management. Clin Toxicol (Phila) 2006; 44:357.</a></li><li><a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/abstract/9\" class=\"nounderline abstract_t\">K&ouml;ppel C, Martens F, Schirop T, Ibe K. Hemoperfusion in acute camphor poisoning. Intensive Care Med 1988; 14:431.</a></li><li><a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/abstract/10\" class=\"nounderline abstract_t\">Love JN, Sammon M, Smereck J. Are one or two dangerous? Camphor exposure in toddlers. J Emerg Med 2004; 27:49.</a></li><li><a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/abstract/11\" class=\"nounderline abstract_t\">Phelan WJ 3rd. Camphor poisoning: over-the-counter dangers. Pediatrics 1976; 57:428.</a></li><li><a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/abstract/12\" class=\"nounderline abstract_t\">Geller RJ, Spyker DA, Garrettson LK, Rogol AD. Camphor toxicity: development of a triage strategy. Vet Hum Toxicol 1984; 26 Suppl 2:8.</a></li><li><a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/abstract/13\" class=\"nounderline abstract_t\">Gibson DE, Moore GP, Pfaff JA. Camphor ingestion. Am J Emerg Med 1989; 7:41.</a></li><li><a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/abstract/14\" class=\"nounderline abstract_t\">Santos CD, Cabot JC. Persistent effects after camphor ingestion: a case report and literature review. J Emerg Med 2015; 48:298.</a></li><li><a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/abstract/15\" class=\"nounderline abstract_t\">Weiss J, Catalano P. Camphorated oil intoxication during pregnancy. Pediatrics 1973; 52:713.</a></li><li><a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/abstract/16\" class=\"nounderline abstract_t\">Antman E, Jacob G, Volpe B, et al. Camphor overdosage. Therapeutic considerations. N Y State J Med 1978; 78:896.</a></li><li><a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/abstract/17\" class=\"nounderline abstract_t\">Reid FM. Accidental camphor ingestion. JACEP 1979; 8:339.</a></li><li><a href=\"https://www.uptodate.com/contents/camphor-poisoning-in-children/abstract/18\" class=\"nounderline abstract_t\">Theis JG, Koren G. Camphorated oil: still endangering the lives of Canadian children. CMAJ 1995; 152:1821.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 94659 Version 5.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H2214514\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H2214023\" id=\"outline-link-H2214023\">INTRODUCTION</a></li><li><a href=\"#H2214222\" id=\"outline-link-H2214222\">EPIDEMIOLOGY</a></li><li><a href=\"#H2213331\" id=\"outline-link-H2213331\">PHARMACOLOGY AND TOXICITY</a><ul><li><a href=\"#H2214049\" id=\"outline-link-H2214049\">Formulations</a></li><li><a href=\"#H2214055\" id=\"outline-link-H2214055\">Mechanism of action</a></li><li><a href=\"#H2214061\" id=\"outline-link-H2214061\">Pharmacokinetics</a></li><li><a href=\"#H2214067\" id=\"outline-link-H2214067\">Toxic amount</a></li></ul></li><li><a href=\"#H2213337\" id=\"outline-link-H2213337\">CLINICAL FEATURES</a></li><li><a href=\"#H2213343\" id=\"outline-link-H2213343\">DIAGNOSIS</a></li><li><a href=\"#H2213349\" id=\"outline-link-H2213349\">DIFFERENTIAL DIAGNOSIS</a></li><li><a href=\"#H2213355\" id=\"outline-link-H2213355\">MANAGEMENT</a><ul><li><a href=\"#H2214073\" id=\"outline-link-H2214073\">Decontamination</a></li><li><a href=\"#H2214079\" id=\"outline-link-H2214079\">Asymptomatic</a></li><li><a href=\"#H2214085\" id=\"outline-link-H2214085\">Seizures</a></li></ul></li><li><a href=\"#H2214719\" id=\"outline-link-H2214719\">ADDITIONAL RESOURCES</a></li><li><a href=\"#H3150763423\" id=\"outline-link-H3150763423\">SOCIETY GUIDELINE LINKS</a></li><li><a href=\"#H2214514\" id=\"outline-link-H2214514\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"EM/94659|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=EM/94904\" class=\"graphic graphic_table\">- Topical camphor products</a></li><li><a href=\"image.htm?imageKey=EM/71268\" class=\"graphic graphic_table\">- Common poisoning syndromes - toxidromes</a></li><li><a href=\"image.htm?imageKey=PEDS/55368\" class=\"graphic graphic_table\">- Management of status epilepticus in children</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=causes-of-hypoglycemia-in-infants-and-children\" class=\"medical medical_review\">Causes of hypoglycemia in infants and children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=child-abuse-evaluation-and-diagnosis-of-abusive-head-trauma-in-infants-and-children\" class=\"medical medical_review\">Child abuse: Evaluation and diagnosis of abusive head trauma in infants and children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-features-and-complications-of-status-epilepticus-in-children\" class=\"medical medical_review\">Clinical features and complications of status epilepticus in children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=etiology-of-hypocalcemia-in-infants-and-children\" class=\"medical medical_review\">Etiology of hypocalcemia in infants and children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hyponatremia-in-children\" class=\"medical medical_review\">Hyponatremia in children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=isoniazid-inh-poisoning\" class=\"medical medical_review\">Isoniazid (INH) poisoning</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-convulsive-status-epilepticus-in-children\" class=\"medical medical_review\">Management of convulsive status epilepticus in children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=over-the-counter-cough-and-cold-preparations-approach-to-pediatric-poisoning\" class=\"medical medical_review\">Over-the-counter cough and cold preparations: Approach to pediatric poisoning</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-general-measures-for-acute-poisoning-treatment\" class=\"medical medical_society_guidelines\">Society guideline links: General measures for acute poisoning treatment</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=theophylline-poisoning\" class=\"medical medical_review\">Theophylline poisoning</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=tricyclic-antidepressant-poisoning\" class=\"medical medical_review\">Tricyclic antidepressant poisoning</a></li></ul></div></div>","javascript":null}